Прогноз развития пневмоний у больных с нарушениями иммунитета на фоне онкогематологической патологии

І. С. Борисова

Аннотация


В исследовании на основе статистического анализа комплекса клинико-лабораторных, анамнестических и иммунологических показателей 495 больных с нарушениями иммунитета на фоне онкогематологической патологии определены предикторы развития пневмоний и создана регрессионная логистическая модель прогноза развития пневмоний, куда вошли показатели, которые характеризуют течение онкогематологического заболевания и состояние иммунной системы.

Ключевые слова


прогноз развития пневмонии; онкогематологическая патология; нарушение иммунитета

Полный текст:

PDF (English)

Литература


Torres A., Niederman M.S., Chastre J. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur. Respir J. 2017; 50 (3). https://doi.org/10.1183/13993003.00582-2017

Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. J. Respir. Crit. Care Med. 2005; 171: 388–416. https://doi.org/10.1164/rccm.200405-644ST

Management of Adults With Hospital Acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. https://dx.doi.org/10.1093%2Fcid%2Fciw353

Nakaz MOZ Ukraїni «Pro zatverdzhennya klіnіchnikh protokolіv nadannya medichnoї dopomogi za spetsіal’nіstyu «Pul’monologіya» [Unorthodontic and nosocomial (hospital) pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antibiotic therapy (methodical recommendations)]. K.: Veles. 2007:105–146р. Ukrainian.

Natsіonal’na akademіya nauk Ukraїni. Tsentr medichnoї statistiki Ukraїni MOZ Ukraїni. Derzhavna ustanova «Natsіonal’niy іnstitut ftizіatrії і pul’monologії іm. F.G. Yanovs’kogo AMN Ukraїni» [Portovnyalny dany about rozpovsuzhenzhenost zabor organiiv dihannya I medichnu dopomogu govorim pulmonologіchnogo profilju in Ukraini for 2008-2014 rr.]. Kiїv. 2014. Ukrainian. http://www.ifp.kiev.ua/doc/staff/pulmukr2014.pdf

Cancer Facts & Figures. GA: American Cancer Society. 2017. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf

Sivkovych S.O., Zinchenko V.N., Zubryts’ka T.B. State of medical care of patients with hematological malignancies in Kyїv. Lik Sprava. 2012 Dec;(8):134–40.

[Clinical immunology and allergology]. 2011:550 р. Ukrainian.

Voytsekhovskiy V.V., Esenina T.V., Filatova E.A., Makarova N.V. [Infectious complications of hemoblastoses during programmed chemotherapy]. Amurskiy meditsinskiy zhurnal. 2011; 6:10–20. Russian.

Toropova I.Yu., Parovichnikova E.N., Klyasova G.A. [Clinical monitoring of infectious complications in patients with hemoblastomas on the background of programmed chemotherapy] Gematologiya i transfuziologiya. 2011; 6: 10–20. Russian.

Lekhan V.M., Voronenko Yu.V., Maksimenko O.P. [Epidemiological methods for the study of non-infectious diseases: a manual]. 2004, 184 p. Ukrainian.

Nakaz MOZ Ukraїni «Pro zatverdzhennya protokolіv nadannya medichnoї dopomogi za spetsіal’nіstyu «Onkologіya» vіd 30.07.2010 r. № 647 іz dopovnennyami zgіdno: Nakazu MOZ Ukraїni vіd 30.01.2013 № 72; Nakazu MOZ Ukraїni vіd 02.11.2015 № 709; Nakazu MOZ Ukraїni vіd 02.11.2015 № 711; Nakazu MOZ Ukraїni vіd 02.11.2015 № 710; Nakazu MOZ Ukraїni vіd 26.06.2014 № 433. [Standards of diagnosis and treatment of cancer patients]. Ukrainian.

Lang T.A. [How to describe statistics in medicine. Guidelines for authors, editors and reviewers]. Moskva: Prakticheskaya meditsina. 2016: 480 р. Russian.

Šimundić A.M. Measures of Diagnostic Accuracy: Basic Definitions. EJIFCC. 2009; 19(4): 203–211.

Pertseva T.O., Borisova І.S. [Peculiarities of the course of pneumonia in patients with immune disorders in hemoblastoses]. Medichnі perspektivi. 2012; 1:32–39. Ukrainian.

Taj M., Farzana T., Shah T. Clinical and Microbiological Profile of Pathogens in Febrile Neutropenia in Hematological Malignancies: A Single Center Prospective Analysis. Journal of Oncology. 2015: 5. http://dx.doi.org/10.1155/2015/596504

Bakulina E.S. [Features of hemopoietic disorders in patients with multiple myeloma on the background of cytostatic therapy with alkeran-containing regimens and bortezomib]. Аvtoref. dis. na zdobuttya stupenya kand. med. nauk : spets. 14.01.21 Gematologiya i perelivanie krovi” Moskva. 2013, 25. Russian.

Peshikova M.V. [Clinical and immunological features of infectious complications in children with acute lymphoblastic leukemia and non-B-cell non-Hodgkin’s lymphomas receiving chemotherapy according to the BFM-ALL-90 protocol (M)]. Аvtoref. dis. na zdobuttya stupenya kand. med. nauk. Chelyabinsk. 2004: 24 р. Russian.




Copyright (c) 2018 Семейная медицина

Creative Commons License
Эта работа лицензирована Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN 2412-8708 (Online), ISSN 2307-5112 (Print)

Flag Counter